BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36458007)

  • 1. Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma.
    Wang F; Zhang W; Chai Y; Wang H; Liu Z; He Y
    Front Immunol; 2022; 13():1015436. PubMed ID: 36458007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of an enhanced computed tomography radiomics model for non-invasively predicting granzyme A in head and neck squamous cell carcinoma by machine learning.
    Hang R; Bai G; Sun B; Xu P; Sun X; Yan G; Zhang W; Wang F
    Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3353-3364. PubMed ID: 36920557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CT-based Deep Learning Radiomics Nomogram for the Prediction of EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma.
    Zheng YM; Pang J; Liu ZJ; Yuan MG; Li J; Wu ZJ; Jiang Y; Dong C
    Acad Radiol; 2024 Feb; 31(2):628-638. PubMed ID: 37481418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
    Zheng YM; Yuan MG; Zhou RQ; Hou F; Zhan JF; Liu ND; Hao DP; Dong C
    Eur Radiol; 2022 Aug; 32(8):5362-5370. PubMed ID: 35298679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics Features on Enhanced Computed Tomography Predict FOXP3 Expression and Clinical Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
    Wang Y; Ye J; Zhou K; Chen N; Huang G; Feng G; Zhang G; Gou X
    J Imaging Inform Med; 2024 Feb; ():. PubMed ID: 38376584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CT-Based Deep Learning Radiomics Nomogram to Predict Histological Grades of Head and Neck Squamous Cell Carcinoma.
    Zheng YM; Che JY; Yuan MG; Wu ZJ; Pang J; Zhou RZ; Li XL; Dong C
    Acad Radiol; 2023 Aug; 30(8):1591-1599. PubMed ID: 36460582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-energy CT-based radiomics nomogram in predicting histological differentiation of head and neck squamous carcinoma: a multicenter study.
    Li Z; Liu Z; Guo Y; Wang S; Qu X; Li Y; Pan Y; Zhang L; Su D; Yang Q; Tao X; Yue Q; Xian J
    Neuroradiology; 2022 Feb; 64(2):361-369. PubMed ID: 34860278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
    Zheng YM; Zhan JF; Yuan MG; Hou F; Jiang G; Wu ZJ; Dong C
    Eur J Radiol; 2022 Jan; 146():110093. PubMed ID: 34890937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer.
    Wang K; Zhou Z; Wang R; Chen L; Zhang Q; Sher D; Wang J
    Med Phys; 2020 Oct; 47(10):5392-5400. PubMed ID: 32657426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the MVCT-based radiomic features as prognostic factor in patients with head and neck squamous cell carcinoma.
    Abe K; Kadoya N; Ito K; Tanaka S; Nakajima Y; Hashimoto S; Suda Y; Uno T; Jingu K
    BMC Med Imaging; 2023 Aug; 23(1):102. PubMed ID: 37528392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
    Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
    J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Computed Tomography Radiomic and Genomic Assessment of Head and Neck Squamous Cell Carcinoma.
    Wang CY; Foy JJ; Siewert TY; Haraf DJ; Ginat DT
    J Comput Assist Tomogr; 2020; 44(4):546-552. PubMed ID: 32697524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary Computed Tomography Radiomics Model for Predicting Pretreatment CD8+ T-Cell Infiltration Status for Primary Head and Neck Squamous Cell Carcinoma.
    Wang CY; Ginat DT
    J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):629-636. PubMed ID: 34519454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of predictive and prognostic models for outcome prediction using positron emission tomography radiomics in head and neck squamous cell carcinoma patients.
    Philip MM; Welch A; McKiddie F; Nath M
    Cancer Med; 2023 Aug; 12(15):16181-16194. PubMed ID: 37353996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
    Zhu Y; Mohamed ASR; Lai SY; Yang S; Kanwar A; Wei L; Kamal M; Sengupta S; Elhalawani H; Skinner H; Mackin DS; Shiao J; Messer J; Wong A; Ding Y; Zhang L; Court L; Ji Y; Fuller CD
    JCO Clin Cancer Inform; 2019 Feb; 3():1-9. PubMed ID: 30730765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomic biomarkers for head and neck squamous cell carcinoma.
    Tanadini-Lang S; Balermpas P; Guckenberger M; Pavic M; Riesterer O; Vuong D; Bogowicz M
    Strahlenther Onkol; 2020 Oct; 196(10):868-878. PubMed ID: 32495038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma.
    Li R; Dong J; Zhang H; Zhao Q; Li X; Liu X; Ye Y; Deng S; Lin D; Zheng J; Zuo Z
    Genomics; 2020 Sep; 112(5):3448-3454. PubMed ID: 32569729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
    Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
    Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.